Research Alliance Corp. II

Research Alliance Corp. II (Nasdaq: RACB) is a blank check company formed to pursue a merger, capital stock exchange, asset acquisition, or similar business combination in the healthcare and life sciences sector. Sponsored by Research Alliance Corp. II LLC, the vehicle completed its initial public offering in 2021 as a follow-on to the sponsor team's inaugural SPAC. The company filed an 8-K with the Securities and Exchange Commission on December 6, 2022, accession number 0001104659-22-124898, reflecting a material corporate update during its search period. RACB represents the sponsor group's continued focus on identifying targets within the healthcare technology and life sciences landscape. Sign up for SpacDesk to access full filing history, deal timelines, and real-time status tracking for RACB and hundreds of other active and legacy SPACs.